Fadel Alshalabi, owner and CEO of Crestar Labs, and Samuel Harris, owner of Flojo Recruiting, conspired to bill Medicare and Medicaid for millions of dollars in genetic test orders.
The research team tested the activity of over 2,600 different RNA sequences predicted to belong to a class of RNA enzymes called "twister ribozymes," which have the ability to cut themselves in two.